Market Cap: $1.83B
SI
Schrödinger, Inc.
SDGR
NASDAQUSD
Market Cap: $1.83B
Schrödinger Poised to Reveal Financial Insights Amidst Ongoing Innovation in Molecular Science Schrödinger, a leader in the realm of computational molecular discovery, prepares to announce its fourth-…
Schrödinger Enhances Talent Acquisition Strategy with Restricted Stock Units Schrödinger, Inc. makes a strategic move in attracting top talent by granting restricted stock units (RSUs) to four new emp…
Schrödinger's Strategic Talent Acquisition Boosts Innovative Potential Schrödinger, Inc. continues to strengthen its workforce and enhance its innovative capabilities with the recent grant of restrict…
Schrödinger’s Innovations at the Forefront of Molecular Discovery Schrödinger, Inc. is positioning itself as a leader in the field of molecular discovery, leveraging over three decades of expertise in…
Schrödinger Accelerates Toxicology Risk Prediction in Drug Discovery Schrödinger, Inc. is intensifying its commitment to enhancing its computational platform designed to predict toxicology risks early…
Schrödinger Enhances Computational Platform to Tackle Drug Toxicity Risks Schrödinger, Inc. is intensifying its focus on improving its computational platform designed to predict toxicology risks early…
Schrödinger and Novartis Forge Strategic Collaboration to Enhance Drug Discovery Schrödinger, Inc. has entered into a significant research collaboration and licensing agreement with Novartis, marking…
Schrödinger Advances Drug Discovery Through Innovative Computational Platform Schrödinger, a pioneer in the realm of computational drug discovery, continues to redefine the approach to therapeutic and…
Schrödinger's Innovative Approach to Drug Discovery Takes Center Stage Schrödinger, a pioneering company in the field of computational drug discovery, prepares to participate in a fireside chat at the…
Schrödinger Advances Drug Discovery with Innovative Computational Platform Schrödinger, a leader in physics-based computational platforms for drug discovery and material sciences, continues to redefin…
Schrödinger Prepares for Q3 2024 Financial Results While Advancing Drug Discovery Innovations Schrödinger, a leader in the field of computational drug discovery, is poised to announce its third quarte…